Solventum Corporation (KB7)
XSTU
Real-time Data
06:00 AM
Day's Range
75.6052 wk Range
53.60Overview - KB7 - Solventum Corporation
Key Statistics
Valuation
Enterprise Value
15.35B
P/E (Trailing)
‪11.11‬
PEG Ratio
‪5.77‬
Price / Sales (TTM)
‪1.59‬
Price / Book
‪3.19‬
EV / EBITDA
‪15.74‬
Profitability
Gross Margin
‪58.21%‬
Profit Margin
‪17.25%‬
Operating Margin
‪9.77%‬
Return on Assets
‪2.69%‬
Return on Equity
‪33.96%‬
Ownership
Shares Outstanding
170.11M
Float
144.13M
Held by Insiders
‪15.31%‬
Held by Institutions
‪76.01%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪70.37‬
200-Day Avg
‪65.78‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - KB7 - Solventum Corporation
Peers - KB7 - Solventum Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XSTU.
- KB7XSTUSolventum Corporation12.97BMarket Cap+17.46%52-week change11.02P/E (Trailing)‪17.25%‬Profit Margin
- 2U3XSTUAlcon Inc.31.35BMarket Cap-10.71%52-week change106.25P/E (Trailing)‪55.23%‬Profit Margin
- AVGXSTUAvantor Inc.8.33BMarket Cap+9.24%52-week change11.15P/E (Trailing)‪-8.80%‬Profit Margin
- BTLXSTUBaxter International Inc.7.88BMarket Cap+7.17%52-week change-12.07P/E (Trailing)‪30.05%‬Profit Margin
- H3QXSTUDynavox Group AB (publ)734.50MMarket Cap-69.45%52-week change35.66P/E (Trailing)‪8.84%‬Profit Margin
Profile Summary - KB7 - Solventum Corporation
About
Solventum Corporation is a global healthcare company that develops, manufactures, and commercializes a broad portfolio of medical technologies and solutions. Its primary focus is enabling better, smarter, safer healthcare across clinical settings by combining material science, data science, and digital capabilities.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
